A review of bioanalytical methods for chronic lymphocytic leukemia drugs and metabolites in biological matrices

Quantitation of drugs used for the treatment of chronic lymphocytic leukemia in various biological matrices during both pre-clinical and clinical developments is very important, often in routine therapeutic drug monitoring. The first developed methods for quantitation were traditionally done on LC in combination with either UV or fluorescence detection. However, the emergence of LC with mass spectrometry in tandem in early 1990s has revolutionized the quantitation as it has provided better sensitivity and selectivity within a shorter run time; therefore it has become the choice of method for the analysis of various drugs. In this article, an overview of various bioanalytical methods (HPLC or LC–MS/MS) for the quantification of drugs for the treatment of chronic lymphocytic leukemia, along with applicability of these methods, is given.     

盐酸苯达莫司汀的合成工艺研究

盐酸苯达莫司汀是用于治疗慢性淋巴细胞性白血病(CLL)及乳腺癌的药物,市场前景广阔[1]。目前的合成方法中存在反应条件苛刻、产率低等缺点。本文以2,4-二硝基氯苯为原料,通过取代、还原、酰化、环合、催化还原、烃基化、成盐等七步反应成功合成盐酸苯达莫司汀,终产率为40.99%。反应条件温和、步骤少,降低了生产成本以及设备要求,有良好的工业化应用前景。     

盐酸苯达莫司汀的合成

以2,4-二硝基氯苯为起始原料,依次经甲胺化,选择性还原,N-酰化,环合,催化氢化,N-二羟乙基化,O-甲磺酰化,氯置换,酸化水解和成盐等10步反应合成盐酸苯达莫司汀,其结构经¹H NMR确证,总收率48.4%,纯度99.5%。